Patents by Inventor Darryl L. Carter

Darryl L. Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180291114
    Abstract: The present invention relates generally to the field of generating fusion proteins to be used in cancer therapy, and more specifically, a bispecific T-Cell engager recombinant polypeptide comprising an antibody, fragment thereof, or single chain variable fragment that binds to CD3 of a T-cell antigen receptor and an antibody, fragment thereof, or single chain variable fragment that binds to Programmed Death Ligand 1 (PDL1) on a cancerous tumor cell to counteract the immune tolerance of cancer cells.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Inventors: Suzanne Ostrand-Rosenberg, Darryl L. Carter
  • Publication number: 20150328286
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: July 20, 2015
    Publication date: November 19, 2015
    Inventor: Darryl L. Carter
  • Patent number: 9084759
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: July 21, 2015
    Assignee: Nora Therapeutics, Inc.
    Inventor: Darryl L. Carter
  • Publication number: 20130280207
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: June 24, 2013
    Publication date: October 24, 2013
    Inventor: Darryl L. Carter
  • Patent number: 8491882
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: July 23, 2013
    Assignee: Nora Therapeutics, Inc.
    Inventor: Darryl L. Carter
  • Patent number: 8470775
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: June 25, 2013
    Assignee: Nora Therapeutics, Inc.
    Inventor: Darryl L. Carter
  • Patent number: 8338373
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or spontaneous abortion in a recipient of FET, ICSI, GIFT or ZIFT are provided. The methods include administering into a recipient of FET, ICSI, GIFT or ZIFT in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: December 25, 2012
    Assignee: Nora Therapeutics, Inc.
    Inventor: Darryl L. Carter
  • Publication number: 20120315243
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: January 3, 2012
    Publication date: December 13, 2012
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. Carter
  • Publication number: 20120263673
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: December 15, 2011
    Publication date: October 18, 2012
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. Carter
  • Publication number: 20110229436
    Abstract: Compositions, kits and methods for the prevention of, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction are provided. The compositions, kits and methods provide an effective amount of granulocyte colony stimulating factor to prevent, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure of an embryo.
    Type: Application
    Filed: May 11, 2011
    Publication date: September 22, 2011
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER
  • Publication number: 20110171168
    Abstract: An analog of human granulocyte colony stimulating factor (hG-CSF analog) is disclosed. The hG-CSF analog comprises an amino acid sequence that differs from the wild-type hG-CSF sequence at position 17 and at least one other position, and is capable of preventing trophoblast cell apoptosis. Also disclosed is pharmaceutical compositions comprising the hG-CSF analog, polynucleotides encoding the hG-CSF analog, expression vectors containing the polynucleotides, host cells containing the expression vectors, as well as a method for preventing spontaneous abortion using the hG-CSF analog.
    Type: Application
    Filed: July 21, 2008
    Publication date: July 14, 2011
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. Carter
  • Publication number: 20110104106
    Abstract: Methods and kits for preventing or reducing the likelihood of preterm labor in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: November 22, 2010
    Publication date: May 5, 2011
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER
  • Publication number: 20110104107
    Abstract: Methods and kits for preventing or reducing the likelihood of preeclampsia in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: November 22, 2010
    Publication date: May 5, 2011
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER
  • Publication number: 20110097382
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure and pregnancy-related disorders in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: November 22, 2010
    Publication date: April 28, 2011
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER
  • Publication number: 20110097304
    Abstract: Methods and kits for preventing or reducing the likelihood of spontaneous abortion in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: November 15, 2010
    Publication date: April 28, 2011
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER
  • Publication number: 20100158972
    Abstract: Compositions, kits and methods for the prevention of, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction are provided. The compositions, kits and methods provide an effective amount of granulocyte colony stimulating factor to prevent, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure of an embryo.
    Type: Application
    Filed: March 1, 2010
    Publication date: June 24, 2010
    Applicant: NORA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER
  • Publication number: 20100080837
    Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or spontaneous abortion in a recipient of FET, ICSI, GIFT or ZIFT are provided. The methods include administering into a recipient of FET, ICSI, GIFT or ZIFT in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
    Type: Application
    Filed: October 27, 2009
    Publication date: April 1, 2010
    Applicant: NOVA THERAPEUTICS, INC.
    Inventor: Darryl L. CARTER